Status:
RECRUITING
A Prospective Observational Study of Foam Sclerotherapy .
Lead Sponsor:
Mayo Clinic
Conditions:
Autosomal Dominant Polycystic Kidney
Renal Cyst
Eligibility:
All Genders
18-100 years
Brief Summary
An observational prospective study to determine the impact of foam sclerotherapy of large, dominant kidney/liver cysts on quality of life outcomes and kidney/liver cyst volumes at up to 12 months of f...
Detailed Description
Cyst burden is an important determinant of outcomes in both autosomal dominant polycystic kidney disease (ADPKD) (1, 2) and autosomal dominant polycystic liver disease (ADPLD) (3, 4). Furthermore, mas...
Eligibility Criteria
Inclusion
- Age ≥18 years
- Clinical diagnosis of ADPKD or ADPLD
- 1-3 large, non-exophytic liver or kidney cyst
- Compressive symptoms from dominant cyst
Exclusion
- Age \<18 years
- Absence of ADPKD or ADPLD
- Largest cyst \<4cm in all 3 dimensions or largest cyst volume \<400cc
- \>3 large, non-exophytic liver or kidney cyst(s) ≥4cm in all 3 dimensions (cyst volume ≥400cc)
- Unwilling to comply with study follow-up protocol to 12 ± 1months post-FS
- Lacking capacity to provide informed consent to FS of liver or kidney cysts
- Pregnancy
Key Trial Info
Start Date :
November 6 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2027
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04111692
Start Date
November 6 2017
End Date
November 1 2027
Last Update
December 27 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic
Rochester, Minnesota, United States, 55905